(2R)-2-hydroxy-2-[(2S,3S,5R,6S)-2-hydroxy-6-[[(4R,5R,6R,7R,9S)-2-[(2R,3R,5S)-5-[(2R,5R)-5-[(2S,3S,5R,6S)-6-hydroxy-3,5,6-trimethyloxan-2-yl]oxolan-2-yl]-3-[(2S,5S,6R)-5-methoxy-6-methyloxan-2-yl]oxyoxolan-2-yl]-7-methoxy-2,4,6-trimethyl-1,10-dioxaspiro[4.5]decan-9-yl]methyl]-4-methoxy-3,5-dimethyloxan-2-yl]acetic acid

Term ID

CHEBI:223690

Synonyms

(2R)-2-hydroxy-2-[(2S,3S,5R,6S)-2-hydroxy-6-[[(4R,5R,6R,7R,9S)-2-[(2R,3R,5S)-5-[(2R,5R)-5-[(2S,3S,5R,6S)-6-hydroxy-3,5,6-trimethyloxan-2-yl]oxolan-2-yl]-3-[(2S,5S,6R)-5-methoxy-6-methyloxan-2-yl]oxyoxolan-2-yl]-7-methoxy-2,4,6-trimethyl-1,10-dioxaspiro[4.

Definition

References

Chemspider:78443121

Ontology

ChEBI ( EBI )

Relationships

is a type of: C-glycosyl compound

C-glycosyl compound Show first 5 Terms

Phenotype

Phenotype resulting from (2R)-2-hydroxy-2-[(2S,3S,5R,6S)-2-hydroxy-6-[[(4R,5R,6R,7R,9S)-2-[(2R,3R,5S)-5-[(2R,5R)-5-[(2S,3S,5R,6S)-6-hydroxy-3,5,6-trimethyloxan-2-yl]oxolan-2-yl]-3-[(2S,5S,6R)-5-methoxy-6-methyloxan-2-yl]oxyoxolan-2-yl]-7-methoxy-2,4,6-trimethyl-1,10-dioxaspiro[4.5]decan-9-yl]methyl]-4-methoxy-3,5-dimethyloxan-2-yl]acetic acid

Phenotype where environments contain (2R)-2-hydroxy-2-[(2S,3S,5R,6S)-2-hydroxy-6-[[(4R,5R,6R,7R,9S)-2-[(2R,3R,5S)-5-[(2R,5R)-5-[(2S,3S,5R,6S)-6-hydroxy-3,5,6-trimethyloxan-2-yl]oxolan-2-yl]-3-[(2S,5S,6R)-5-methoxy-6-methyloxan-2-yl]oxyoxolan-2-yl]-7-methoxy-2,4,6-trimethyl-1,10-dioxaspiro[4.5]decan-9-yl]methyl]-4-methoxy-3,5-dimethyloxan-2-yl]acetic acid

Phenotype modified by environments containing (2R)-2-hydroxy-2-[(2S,3S,5R,6S)-2-hydroxy-6-[[(4R,5R,6R,7R,9S)-2-[(2R,3R,5S)-5-[(2R,5R)-5-[(2S,3S,5R,6S)-6-hydroxy-3,5,6-trimethyloxan-2-yl]oxolan-2-yl]-3-[(2S,5S,6R)-5-methoxy-6-methyloxan-2-yl]oxyoxolan-2-yl]-7-methoxy-2,4,6-trimethyl-1,10-dioxaspiro[4.5]decan-9-yl]methyl]-4-methoxy-3,5-dimethyloxan-2-yl]acetic acid

Human Disease Model